Immunology, Inflammation, Infectiology and Microbiology Institute Live

IMMI, backed by AstraZeneca: 2014 requests for proposals on 'the ultra-rapid diagnosis of resistance to antibiotics' and 'the characterisation of new antibiotic targets'




Backed by AstraZeneca, IMMI is launching two requests for proposals in the field of antibiotic resistance on the 'ultra-rapid diagnosis of resistance to antibiotics' and 'the characterisation of new antibiotic targets'.

Basic and clinical research on administration routes of vaccines




On 30 May 2013, Pasteur Institute (Paris)
Organization: Consortium de recherche en vaccinologie (CoReVac), Pasteur Institute, Inserm, Aviesan
Attendance to be confirmed before 30 April 2013

Programme (CoReVac) (585.0 ko) 

Contact :

Actualités sur les Maladies infectieuses émergentes - 1er séminaire Maladies Infectieuses Émergentes du 9 novembre 2011




Ce séminaire a réuni à Paris, experts, gestionnaires de crise et décideurs politiques. Une dynamique s’est créée. Découvrez les quatre points forts que les débats ont dégagés.
Lire les Actes du séminaire "Maladies infectieuses émergentes" du 9 novembre 2011 : actualités et propositions
Lire la synthèse

Information meeting on the IRT BIOASTER




On April 12, 2012 at the auditorium of the Institut Pasteur’s Scientific Information Center (CIS) in Paris (15th arrondissement)
Organized by: Technological Research Institute (IRT) BIOASTER (formerly LyonBiotech)

Find out more (IRT) (203.6 ko) 

Online registration mandatory
Contact:, Tel.: +33 (0)1 45 68 81 92

Institut de Recherche Biomédicale des Armées (IRBA – Armed Forces Biomedical Research Institute) - Aviesan, the French National Alliance for Life and Health Sciences: Scientific seminar




This scientific seminar, the first of its kind, will take place on 7 October 2011 in Paris (Ecole du Val-de-Grâce). It aims to establish new scientific partnerships between the teams from IRBA and those from within AVIESAN more generally. It is structured around two main themes: the health consequences of emotional stress and topical issues in vector-borne diseases. A round table discussion will be used to identify potential scientific interactions between IRBA and Aviesan components, as well as the objectives and methods to establish for these new partnerships. The full programme will be available shortly.

To know more (30.9 ko) 
View Edit Create here